Skip to content
Stop using now Drug recall · FDA · Published February 1, 2024

Insight TING Athlete's Foot Spray Recall: Benzene Chemical Contamination Hazard

Insight Pharmaceuticals recalls TING 1% Tolnaftate Athlete's Foot Spray due to benzene contamination. Affected lots expire 07/31/24 or 06/30/25. Stop using immediately to avoid chemical exposure.

🇺🇸 FDA recall #D-0346-2024DrugInsight ›
Take action

Contact the company

Recalling firmInsight Pharmaceuticals LLC, a Prestige Consumer Healthcare company660 White Plains Rd Ste 250 · Tarrytown, NY 10591-5171
✎ GovInfoNow plain-language explainer

Insight Pharmaceuticals recalls TING Athlete's Foot Spray cans containing benzene contamination. This chemical hazard could cause injury if used, so affected users should stop using the product immediately. Read more at govinfonow.com/recall/32840-insight-ting-athlete-s-foot-spray-recall-benzene-chemical-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/32840-insight-ting-athlete-s-foot-spray-recall-benzene-chemical-contamination · Updated August 17, 2026 · FDA enforcement record: FDA #D-0346-2024

Cite this page

“Insight TING Athlete's Foot Spray Recall: Benzene Chemical Contamination Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32840-insight-ting-athlete-s-foot-spray-recall-benzene-chemical-contamination. Based on FDA recall #D-0346-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0346-2024%22&limit=1).

The FDA announced on Feb. 1, 2024, that Insight Pharmaceuticals LLC is recalling TING 1% Tolnaftate Athlete's Foot Spray due to benzene contamination. The agency classified the Class I recall as voluntary.

How to tell if you have it

  • TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid
  • NET WT 4.5 oz. (128 g) cans
  • UPC 3 63736 81961 3
  • Lot # 0H50545, Exp. date 07/31/24
  • Lot # 1G50645, Exp. date 06/30/25

The hazard

The recall addresses the presence of benzene, a known carcinogen, in the antifungal spray liquid. The FDA classified this as a Class I hazard.

Context

GovInfoNow's records show Insight Pharmaceuticals LLC has 2 other recalls on record since 2023-12-21. On 2023-12-21, the company recalled Americaine benzocaine spray due to benzene contamination. Other recent recalls of similar products include Owen Biosciences Night Lotion Recall (2026-03-03), Sandra Lee MD Acne Spot Treatment Recall (2026-03-03), and Owen Biosciences Recalls Acne Lotion with Benzene Contamination (2026-03-03).

How to tell if you have this one

Check for TING 1% Tolnaftate Athlete's Foot Spray cans labeled with lot numbers 0H50545 (expiring 07/31/24) or 1G50645 (expiring 06/30/25).

  • Brand
    Insight
  • Product
    TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) cans, Distributed by: Insight
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    Discard the recalled TING Athlete's Foot Spray cans to avoid exposure to benzene.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Product was distributed nationwide and to 4 foreign accounts. Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; Accra, Ghana.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: Feb 1, 202412. FDA classified it Class I: Feb 22, 202423. Published in FDA’s Enforcement Report: Feb 28, 202432024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Insight recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0346-2024 (February 1, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0346-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA